BRIEF-Hemispherx Biopharma renews sales, marketing, distribution and supply agreement with GP Pharm

martes 31 de mayo de 2016 08:45 GYT
 

May 31 (Reuters) - Hemispherx Biopharma Inc

* Renews sales, marketing, distribution and supply agreement with GP Pharm

* Granted GP Pharm expanded rights to sell ampligen into other Latin American countries based upon certain performance milestones

* Has also granted GP Pharm an option to market alferon n injection trademarked in Argentina as naturaferon

* GP Pharm will be responsible for gaining regulatory approval in Argentina for ampligen, an experimental therapeutic Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)